51 studies found for:    "Prader-Willi syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Prader-Willi Syndrome and Appetite
Conditions: Hyperphagia;   Prader-Willi Syndrome
Intervention: Drug: Sandostatin LAR
2 Completed Hypoglycemia in Prader-Willi Syndrome
Conditions: Prader Willi Syndrome;   Hypoglycemia
Intervention: Other: Infants with Prader-Willi Syndrome
3 Completed Oxytocin Trial in Prader-Willi Syndrome
Condition: Prader Willi Syndrome
Interventions: Drug: Intranasal oxytocin;   Other: Placebo
4 Active, not recruiting Prader-Willi Syndrome Macronutrient Study
Conditions: Prader Willi Syndrome;   Syndromic Obesity;   Childhood Obesity
Interventions: Other: Low Carbohydrate diet;   Other: Low Fat diet
5 Completed Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Self-Injurious Behavior
Intervention: Drug: Topiramate
6 Unknown  Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Exenatide
7 Completed Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Intervention:
8 Completed Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
Conditions: Prader-Willi Syndrome;   Growth Hormone Deficiency
Interventions: Drug: Growth hormone (Genotonorm® or Omnitrope®);   Procedure: DEXA, blood tests, H.G.P.O, osseous age.;   Procedure: biopsy
9 Unknown  Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study
Conditions: Prader Willi Syndrome;   Childhood Obesity
Intervention: Behavioral: Active Play at Home
10 Recruiting Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Device: Deep Brain Stimulation
11 Completed Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
Conditions: Prader Willi Syndrome;   Obsessive-compulsive Disorder
Interventions: Behavioral: Cognitive-behavioral therapy;   Behavioral: Wait-list control
12 Completed Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome
Conditions: Obesity;   Prader-Willi Syndrome
Intervention:
13 Recruiting Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Hyperphagia
Interventions: Drug: Intranasal Oxytocin (IN-OXT);   Drug: Matched Placebo
14 Completed Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Norditropin SimpleXx
15 Terminated
Has Results
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
Condition: Prader-Willi Syndrome
Interventions: Drug: Octreotide;   Drug: Placebo
16 Completed Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Intervention:
17 Active, not recruiting Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: DCCR;   Drug: Placebo
18 Recruiting Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Interventions: Drug: RM-493;   Drug: Placebo
19 Not yet recruiting Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell
Condition: Prader-Willi Syndrome
Intervention: Drug: Recombinant Somatropin
20 Active, not recruiting Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome;   Obesity
Interventions: Drug: ZGN-440 for Injectable Suspension;   Drug: ZGN-440 Placebo for Injectable Suspension

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years